Universal Health Services Inc.
 (UHS)

- NYSE
What's your position on ?
Bullish
Bearish
Why are you ish?
Skip
Post
You voted ish on Vote again
Posts appear on the My Feed page of subscribers to this ticker
Last vote:
  • Wed, Jan. 20, 5:47 PM
    • Universal Health Services (NYSE:UHS) declares $0.10/share quarterly dividend, in line with previous.
    • Forward yield 0.37%
    • Payable March 15; for shareholders of record March 1; ex-div Feb. 26.
    | Wed, Jan. 20, 5:47 PM
  • Dec. 18, 2015, 12:18 PM
    • Biogen (BIIB +0.2%) initiated with Overweight rating and $344 (16% upside) price target by Atlantic Equities.
    • CVS Health (CVS -0.1%) initiated with Overweight rating and $110 (16% upside) price target by Barclays.
    • Clovis Oncology (CLVS +0.9%) initiated with Buy rating and $50 (48% upside) price target by Janney.
    • Relypsa (RLYP +2.6%) initiated with Buy rating and $63 (123% upside) price target by H.C. Wainwright.
    • HCA Holdings (HCA -0.2%) initiated with Outperform rating and $75 (16% upside) price target; LifePoint Health (LPNT +0.4%) with an Outperform rating and $79 (13% upside) price target; Tenet Healthcare (THC +1.2%) with a Neutral rating and $33 (18% upside) price target and Universal Health Services (UHS +0.4%) with a Neutral rating and $129 (11% upside) price target by Credit Suisse.
    • Amgen (AMGN -0.1%) upgraded to Overweight from Equal Weight by Morgan Stanley. Price target raised to $193 (20% upside) from $160.
    • Valeant Pharmaceuticals (VRX -1.8%) downgraded to Neutral from Buy by Mizuho Securities. Price target raised to $130 (19% upside) from $111.
    | Dec. 18, 2015, 12:18 PM
  • Nov. 18, 2015, 6:07 PM
    • Universal Health Services (NYSE:UHS) declares $0.10/share quarterly dividend, in line with previous.
    • Forward yield 0.32%
    • Payable Dec. 15; for shareholders of record Dec. 1; ex-div Nov. 27.
    | Nov. 18, 2015, 6:07 PM
  • Oct. 27, 2015, 4:28 PM
    • Universal Health Services (NYSE:UHS): Q3 EPS of $1.53 misses by $0.04.
    • Revenue of $2.23B (+9.3% Y/Y) beats by $10M.
    | Oct. 27, 2015, 4:28 PM
  • Oct. 26, 2015, 5:35 PM
  • Sep. 18, 2015, 11:32 AM
    • Universal Health Services (UHS -0.3%) acquires privately-held Foundations Recovery Network LLC for ~$350M. The Brentwood, TN-based firm operates a network of four residential and eight outpatients facilities that offer treatment for mental health and substance abuse problems.
    | Sep. 18, 2015, 11:32 AM | 1 Comment
  • Aug. 25, 2015, 5:35 PM
    • investors should stick with "market darlings" - the 25 stocks that had performed the best during the six months before a market pullback - according to the analyst team at RBC.
    • The firm notes that although many recent winners are leading the market lower, the extent of the underperformance is just 1%; it also says investing in the group following sharp market pullbacks is a winning strategy over the ensuing week, month and six months.
    • RBC's 25 market darlings are AET, ALTR, AMZN, AIZ, CVC, CI, CAG, EA, EQIX, EXPE, GME, GOOGL, HAS, HCA, MNST, NFLX, NKE, PRGO, REGN, SBUX, TSO, TWC, TSS, UA, UHS
    | Aug. 25, 2015, 5:35 PM | 61 Comments
  • Jul. 30, 2015, 5:05 PM
    • Universal Health Services (NYSE:UHS): Q2 EPS of $1.85 beats by $0.22.
    • Revenue of $2.28B (+11.2% Y/Y) beats by $90M.
    | Jul. 30, 2015, 5:05 PM
  • Jul. 15, 2015, 5:03 PM
    • Universal Health Services (NYSE:UHS) declares $0.10/share quarterly dividend, in line with previous.
    • Forward yield 0.28%
    • Payable Sept. 15; for shareholders of record Sept. 1; ex-div Aug. 28.
    | Jul. 15, 2015, 5:03 PM
  • Jun. 12, 2015, 12:17 PM
    • AMAG Pharmaceuticals (AMAG -1.5%) initiated with Hold rating and $75 (10% upside) price target by Deutsche Bank.
    • Supernus Pharmaceuticals (SUPN +9.5%) initiated with Buy rating and $30 (70% upside) price target by SunTrust Robinson Humphrey.
    • Plasmatech Biopharmaceuticals (PTBI -2.7%) initiated with Buy rating and $16 (118% upside) price target by Roth Capital.
    • Horizon Pharma (HZNP -0.4%) initiated with Overweight rating and $38 (19% upside) price target by Morgan Stanley.
    • Depomed (DEPO -2.1%) initiated with Equal Weight rating and $23 (10% upside) price target by Morgan Stanley.
    • Community Health Systems (CYH +0.5%) initiated with Outperform rating and $65 (19% upside) price target by Wedbush.
    • HCA Holdings (HCA -0.1%) initiated with Outperform rating and $93 (11% upside) price target by Wedbush.
    • LifePoint Health (LPNT -0.2%) initiated with Neutral rating and $80 (5% upside) price target by Wedbush.
    • HealthSouth (HLS) initiated with Neutral rating and $46 (3% downside risk) price target by Wedbush.
    • Adeptus Health (ADPT -0.4%) initiated with Overweight rating and $106 (26% upside) price target by KeyBanc.
    • Universal Health Services (UHS -0.1%) initiated with Neutral rating and $141 (7% upside) price target by Janney Capital.
    • Owens & Minor (OMI -0.2%) initiated with Sector Perform rating and $35 (3% upside) price target by RBC Capital.
    • Henry Schein (HSIC -0.6%) initiated with Outperform rating and $165 (16% upside) price target by RBC Capital.
    | Jun. 12, 2015, 12:17 PM | 5 Comments
  • Jun. 9, 2015, 10:55 AM
    • CVS Health (CVS -0.1%) initiated with Outperform rating and $115 (16% upside) price target by Macquarie.
    • Galapagos (GLPG -3%) initiated with Overweight rating and $73 (36% upside) price target by Morgan Stanley.
    • LifePoint Health (LPNT) initiated with Conviction Buy rating and $92 (25% upside) price target by Goldman Sachs.
    • BioMarin Pharmaceutical (BMRN -2.2%) initiated with Overweight rating and $150 (24% upside) price target by Barclays.
    • Universal Health Services (UHS +0.2%) initiated with Neutral rating and $140 (10% upside) price target by Goldman Sachs.
    • Amsurg (AMSG -0.5%) initiated with Buy rating and $81 (17% upside) price target by Goldman Sachs.
    • Momenta Pharmaceuticals (MNTA -2.6%) initiated with Buy rating and $26 (18% upside) price target by Stifel Nicolaus.
    • Actavis (ACT -0.6%) initiated with Outperform rating and $344 (16% upside) price target by Raymond James.
    | Jun. 9, 2015, 10:55 AM
  • May 4, 2015, 12:02 PM
    • Universal Health Services (NYSE:UHS) declares $0.10/share quarterly dividend, in line with previous.
    • Forward yield 0.34%
    • Payable June 15; for shareholders of record June 1; ex-div May 28.
    | May 4, 2015, 12:02 PM
  • Apr. 28, 2015, 10:47 AM
    • Universal Health Services (UHS +0.7%) Q1 results: Revenues: $2,225.4M (+14.8%); Operating Income: $327.1M (+20.7%); Net Income: $174.3M (+26.2%); EPS: $1.73 (+25.4%); Quick Assets: $35.1M (+9.3%); CF Ops: $271.3M (+39.4%).
    • No guidance given.
    | Apr. 28, 2015, 10:47 AM
  • Apr. 27, 2015, 5:04 PM
    • Universal Health Services (NYSE:UHS): Q1 EPS of $1.78 beats by $0.22.
    • Revenue of $2.23B (+14.9% Y/Y) beats by $100M.
    • Shares +2.3% AH.
    | Apr. 27, 2015, 5:04 PM
  • Apr. 26, 2015, 5:35 PM
    | Apr. 26, 2015, 5:35 PM | 18 Comments
  • Apr. 2, 2015, 1:23 PM
    • Retrophin (RTRX +3.7%) rated Outperform with a $48 (98% upside) price target by Leerink Partners.
    • OvaScience (OVAS +8.7%) rated Outperform with a $60 (82% upside) price target by Oppenheimer.
    • OxiGENE (OXGN -0.7%) rated Buy with a $6 (314% upside) price target by H.C. Wainwright.
    • Esperion Therapeutics (ESPR -4.5%) rated Buy with a $140 (40% upside) price target by UBS.
    • Trevena (TRVN -2.3%) rated Outperform with a $15 (110% upside) price target by Wedbush.
    • NewLink Genetics (NLNK -2.3%) downgraded to Hold with a $50 (4% downside risk) price target by Jefferies.
    • Stryker (SYK +0.2%) downgraded to Underweight with a $92 (1% upside) price target by Barclays.
    • Universal Health Services (UHS +2.7%) downgraded to Underperform with a $98 (16% downside risk) price target by Sterne Agee.
    | Apr. 2, 2015, 1:23 PM | 3 Comments
Company Description
Universal Health Services Inc, through its subsidiaries is engaged in the business of owning and operating acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers and radiation oncology centers.
Sector: Healthcare
Industry: Hospitals
Country: United States